Three midlife strategies to prevent cognitive impairment due to Alzheimer's disease

References

• Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement 2013;9:63–75.e2
   PubMed Web of Science ®Google Scholar
• Reitz C, Brayne C, Mayeux R. Epidemiology of Alzheimer disease. Nature Rev Neurol 2011;7:137–52
   PubMed Web of Science ®Google Scholar
• Alzheimer’s Association. 2014 Alzheimer’s disease facts and figures. Alzheimers Dement 2014;10:1–75
   PubMedGoogle Scholar
• Kosik KS, Rapp PR, Raz N, Small SA, Sweatt JD, Tsai LH. Mechanisms of age-related cognitive change and targets for intervention: epigenetics. J Gerontol A Biol Sci Med Sci 2012; 67:741–6
   PubMed Web of Science ®Google Scholar
• Craft S, Foster TC, Landfield PW, Maier SF, Resnick SM, Yaffe K. Mechanisms of age-related cognitive change and targets for intervention: inflammatory, oxidative, and metabolic processes. J Gerontol A Biol Sci Med Sci 2012;67:754–9
   PubMed Web of Science ®Google Scholar
• Pavloppoulos E, Jones S, Kosmidis S, et al. Molecular mechanism for age-related memory loss: the histone-binding protein RbAp48. Sci Transl Med 2013;5:200ra115
   Google Scholar
• Boyle PA, Wilson RS, Yu L, et al. Much of late life cognitive decline is not due to common neurodegenerative pathologies. Ann Neurol 2013;74:478–89
   PubMed Web of Science ®Google Scholar
• Gauthier S, Reisberg B, Zaudig M, et al. Mild cognitive impairment. Lancet 2006;367:1262–70
   PubMed Web of Science ®Google Scholar
• Albert MS, Dekosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging and Alzheimer’s Association workgroup. Alzheimers Dement 2011; 7:270–9
   PubMed Web of Science ®Google Scholar
• Bennett DA, Schneider JA, Arvanitakis Z, et al. Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology 2006;66:1837–44
   PubMed Web of Science ®Google Scholar
• Henderson VW. Gonadal hormones and cognitive aging: a midlife perspective. Womens Health (Lond Engl) 2011;7: 81–93
   PubMedGoogle Scholar
• Guthrie JR, Dennerstein L, Taffe JR, Lehert P, Burger HG. The menopausal transition: a 9-year prospective population-based study. The Melbourne Women’s Midlife Health Project. Climacteric 2004;7:375–89
   Google Scholar
• McKinlay SM, Brambilla DJ, Posner JG. The normal menopause transition. Maturitas 2008;61:4–16
   PubMed Web of Science ®Google Scholar
• Mitchell ES, Woods NF. Cognitive symptoms during the menopausal transition and early postmenopause. Climacteric 2011;14:252–61
   PubMed Web of Science ®Google Scholar
• Ford N, Slade P, Butler G. An absence of evidence linking perceived memory problems to the menopause. Br J Gen Pract 2004;54:434–8
   PubMed Web of Science ®Google Scholar
• Weber MT, Mapstone M, Staskiewicz J, Maki PM. Reconciling subjective memory complaints with objective memory performance in the menopausal transition. Menopause 2012;19: 735–41
   PubMed Web of Science ®Google Scholar
• Salthouse TA. When does age-related cognitive decline begin? Neurobiol Aging 2009;30:507–14
   PubMed Web of Science ®Google Scholar
• Fjell AM, Walhovd KB. Structural brain changes in aging: courses, causes and cognitive consequences. Rev Neurosci 2010;21:187–221
   PubMed Web of Science ®Google Scholar
• Terry RD, Katzman R. Life span and synapses: will there be a primary senile dementia? Neurobiol Aging 2001;22:347–8
   PubMed Web of Science ®Google Scholar
• Henderson VW, Sherwin BB. Surgical versus natural menopause: cognitive issues. Menopause 2007;14:572–9
   PubMed Web of Science ®Google Scholar
• Rocca WA, Bower JH, Ahlskog JE, Grossardt BR, de Andrade M, Melton LJ, 3rd. Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology 2007;69:1074–83
   PubMed Web of Science ®Google Scholar
• Bove R, Secor E, Chibnik LB, et al. Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women. Neurology 2014;82:222–9
   PubMed Web of Science ®Google Scholar
• Ryan J, Stanczyk FZ, Dennerstein L, et al. Hormone levels and cognitive function in postmenopausal midlife women. Neurobiol Aging 2012;33:1138–47
   PubMed Web of Science ®Google Scholar
• Henderson VW, St. John JA, Hodis HN, et al. Cognition, mood, and physiological concentrations of sex hormones in the early and late postmenopause. Proc Natl Acad Sci U S A 2013; 110:20290–5
   PubMed Web of Science ®Google Scholar
• Henderson VW, Popat RA. Effects of endogenous and exogenous estrogen exposures in midlife and late-life women on episodic memory and executive functions. Neuroscience 2011;191:129–38
   PubMed Web of Science ®Google Scholar
• Chen P, Ratcliff G, Belle SH, Cauley JA, DeKosky ST, Ganguli M. Patterns of cognitive decline in presymptomatic Alzheimer disease: a prospective community study. Arch Gen Psychiatry 2001;58:853–8
   PubMed Web of Science ®Google Scholar
• Albert MS, Moss MB, Tanzi R, Jones K. Preclinical prediction of AD using neuropsychological tests. J Int Neuropsychol Soc 2001;7:631–9
   PubMed Web of Science ®Google Scholar
• Asthana S, Gleason CE, Wharton W, et al. The Kronos Early Estrogen Prevention Study: Results of the Cognitive & Affective Sub-Study (KEEPS Cog). Menopause 2012;19:1364
   Google Scholar
• Querfurth HW, LaFerla FM. Alzheimer’s disease. N Engl J Med 2010;362:329–44
   PubMed Web of Science ®Google Scholar
• Braak H, Thal DR, Ghebremedhin E, Del Tredici K. Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol 2011;70:960–9
   PubMed Web of Science ®Google Scholar
• Bateman RJ, Xiong C, Benzinger TL, et al. Clinical and biomarker changes in dominantly inherited Alzheimer’s disease. N Engl J Med 2012;367:795–804
   PubMed Web of Science ®Google Scholar
• Terry RD. Alzheimer’s disease and the aging brain. J Geriatr Psychiatry Neurol 2006;19:125–8
   PubMed Web of Science ®Google Scholar
• Jellinger KA. Pathology and pathogenesis of vascular cognitive impairment-a critical update. Front Aging Neurosci 2013;5:17
   PubMed Web of Science ®Google Scholar
• Launer LJ, Hughes TM, White LR. Microinfarcts, brain atrophy, and cognitive function: the Honolulu Asia Aging Study Autopsy Study. Ann Neurol 2011;70:774–80
   PubMed Web of Science ®Google Scholar
• Dolan D, Troncoso J, Resnick SM, Crain BJ, Zonderman AB, O’Brien RJ. Age, Alzheimer’s disease and dementia in the Baltimore Longitudinal Study of Ageing. Brain 2010;133: 2225–31
   PubMed Web of Science ®Google Scholar
• Schneider JA, Arvanitakis Z, Bang W, Bennett DA. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 2007;69:2197–204
   PubMed Web of Science ®Google Scholar
• Neuropathology Group of the Medical Research Council Cognitive Function and Aging Study. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales: Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Lancet 2001;357:169–75
   PubMed Web of Science ®Google Scholar
• Stampfer MJ. Cardiovascular disease and Alzheimer’s disease: common links. J Intern Med 2006;260:211–23
   PubMed Web of Science ®Google Scholar
• Dolan H, Crain B, Troncoso J, Resnick SM, Zonderman AB, Obrien RJ. Atherosclerosis, dementia, and Alzheimer disease in the Baltimore Longitudinal Study of Aging cohort. Ann Neurol 2010;68:231–40
   PubMed Web of Science ®Google Scholar
• Launer LJ, Petrovitch H, Ross GW, Markesbery W, White LR. AD brain pathology: vascular origins? Results from the HAAS autopsy study. Neurobiol Aging 2008;29:1587–90
   PubMed Web of Science ®Google Scholar
• Bushnell C, McCullough LD, Awad IA, et al. Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014;45:1545–88
   PubMed Web of Science ®Google Scholar
• Stern Y. Cognitive reserve in aging and Alzheimer’s disease. Lancet Neurol 2012;11:1006–12
   PubMed Web of Science ®Google Scholar
• Sharp ES, Gatz M. Relationship between education and dementia: an updated systematic review. Alzheimer Dis Assoc Disord 2011;25:289–304
   PubMed Web of Science ®Google Scholar
• Potter GG, Helms MJ, Plassman BL. Associations of job demands and intelligence with cognitive performance among men in late life. Neurology 2008;70:1803–8
   PubMed Web of Science ®Google Scholar
• Stern C, Munn Z. Cognitive leisure activities and their role in preventing dementia: a systematic review. Int J Evid Based Healthc 2010;8:2–17
   PubMedGoogle Scholar
• Karp A, Paillard-Borg S, Wang HX, Silverstein M, Winblad B, Fratiglioni L. Mental, physical and social components in leisure activities equally contribute to decrease dementia risk. Dement Geriatr Cogn Disord 2006;21:65–73
   PubMed Web of Science ®Google Scholar
• Fratiglioni L, Wang HX, Ericsson K, Mayton M, Winblad B. Influence of social network on occurrence of dementia: a community-based longitudinal study. Lancet 2000;344: 1315–19
   Google Scholar
• Wilson RS, Boyle PA, Yu L, Barnes LL, Schneider JA, Bennett DA. Life-span cognitive activity, neuropathologic burden, and cognitive aging. Neurology 2013;81:314–21
   PubMed Web of Science ®Google Scholar
• Ball K, Berch DB, Helmers KF, et al. Effects of cognitive training interventions with older adults: a randomized controlled trial. JAMA 2002;288:2271–81
   PubMed Web of Science ®Google Scholar
• Rebok GW, Ball K, Guey LT, et al. Ten-year effects of the advanced cognitive training for independent and vital elderly cognitive training trial on cognition and everyday functioning in older adults. J Am Geriatr Soc 2014;62:16–24
   PubMed Web of Science ®Google Scholar
• Martin M, Clare L, Altgassen AM, Cameron MH, Zehnder F. Cognition-based interventions for healthy older people and people with mild cognitive impairment. Cochrane Database Systematic Reviews 2011;1(CD006220)
   Google Scholar
• Sofi F, Valecchi D, Bacci D, et al. Physical activity and risk of cognitive decline: a meta-analysis of prospective studies. J Intern Med 2011;269:107–17
   PubMed Web of Science ®Google Scholar
• Williams JW, Plassman BL, Burke J, Holsinger T, Benjamin S. Preventing Alzheimer’s Disease and Cognitive Decline. Evidence Report/Technology Assessment Number 193. AHRQ Publication No. 10-E005. Rockville, MD: Department of Health and Human Services, 2010
   Google Scholar
• Zhu N, Jacobs DR Jr, Schreiner PJ, et al. Cardiorespiratory fitness and cognitive function in middle age: The CARDIA Study. Neurology 2014;82:1339–46
   PubMed Web of Science ®Google Scholar
• Liu HL, Zhao G, Zhang H, Shi LD. Long-term treadmill exercise inhibits the progression of Alzheimer’s disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice. Behav Brain Res 2013;256:261–72
   PubMed Web of Science ®Google Scholar
• Um HS, Kang EB, Leem YH, et al. Exercise training acts as a therapeutic strategy for reduction of the pathogenic phenotypes for Alzheimer’s disease in an NSE/APPsw-transgenic model. Int J Mol Med 2008;22:529–39
   PubMed Web of Science ®Google Scholar
• Head D, Bugg JM, Goate AM, et al. Exercise engagement as a moderator of the effects of APOE genotype on amyloid deposition. Arch Neurol 2012;69:636–43
   PubMed Web of Science ®Google Scholar
• Bretsky PM, Buckwalter JG, Seeman TE, et al. Evidence for an interaction between apolipoprotein E genotype, gender, and Alzheimer disease. Alzheimer Dis Assoc Disord 1999;13: 216–21
   PubMed Web of Science ®Google Scholar
• Farrer LA, Cupples LA, Haines JL, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. JAMA 1997;278:1349–56
   PubMed Web of Science ®Google Scholar
• Altmann A, Tian L, Henderson VW, Greicius MD, ADNI Investigators. Sex modifies the APOE-related risk of developing Alzheimer’s disease. Ann Neurol 2014;75:563–73
   PubMed Web of Science ®Google Scholar
• Intlekofer KA, Cotman CW. Exercise counteracts declining hippocampal function in aging and Alzheimer’s disease. Neurobiol Dis 2013;57:47–55
   PubMed Web of Science ®Google Scholar
• Erickson KI, Voss MW, Prakash RS, et al. Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci USA 2011;108:3017–22
   PubMed Web of Science ®Google Scholar
• Korol DL, Gold PE, Scavuzzo CJ. Use it and boost it with physical and mental activity. Hippocampus 2013;32:125–35
   Google Scholar
• Kobilo T, Liu QR, Gandhi K, Mughal M, Shaham Y, van Praag H. Running is the neurogenic and neurotrophic stimulus in environmental enrichment. Learn Mem 2011;18:605–9
   PubMed Web of Science ®Google Scholar
• Weinstein G, Beiser AS, Choi SH, et al. Serum brain-derived neurotrophic factor and the risk for dementia: the Framingham heart study. JAMA Neurol 2014;71:55–66
   PubMed Web of Science ®Google Scholar
• Pereira AC, Huddleston DE, Brickman AM, et al. An in vivo correlate of exercise-induced neurogenesis in the adult dentate gyrus. Proc Natl Acad Sci USA 2007;104:5638–43
   PubMed Web of Science ®Google Scholar
• Physical Activity Guidelines writing group. 2008 Physical Activity Guidelines for Americans. Washington, DC: US Department of Health and Human Services, 2008
   Google Scholar
• Vest RS, Pike CJ. Gender, sex steroid hormones, and Alzheimer’s disease. Horm Behav 2013;63:301–7
   PubMed Web of Science ®Google Scholar
• Bailey ME, Wang AC, Hao J, et al. Interactive effects of age and estrogen on cortical neurons: implications for cognitive aging. Neuroscience 2011;191:148–58
   PubMed Web of Science ®Google Scholar
• McClure RE, Barha CK, Galea LA. 17β-Estradiol, but not estrone, increases the survival and activation of new neurons in the hippocampus in response to spatial memory in adult female rats. Horm Behav 2013;63:144–57
   PubMed Web of Science ®Google Scholar
• Ding F, Yao J, Zhao L, Mao Z, Chen S, Brinton RD. Ovariectomy induces a shift in fuel availability and metabolism in the hippocampus of the female transgenic model of familial Alzheimer’s disease. PLoS One 2013;8:e59825
   PubMed Web of Science ®Google Scholar
• Shumaker SA, Legault C, Rapp SR, et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women’s Health Initiative Memory Study (WHIMS). JAMA 2003;289:2651–62
   PubMed Web of Science ®Google Scholar
• Shumaker SA, Legault C, Kuller L, et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women’s Health Initiative Memory Study. JAMA 2004;291:2947–58
   PubMed Web of Science ®Google Scholar
• Henderson VW, Benke KS, Green RC, Cupples LA, Farrer LA. Postmenopausal hormone therapy and Alzheimer’s disease risk: interaction with age. J Neurol Neurosurg Psychiatry 2005; 76:103–5
   PubMed Web of Science ®Google Scholar
• Whitmer RA, Quesenberry CP, Zhou J, Yaffe K. Timing of hormone therapy and dementia: the critical window theory revisited. Ann Neurol 2011;69:163–9
   PubMed Web of Science ®Google Scholar
• Shao H, Breitner JCS, Whitmer RA, et al. Hormone therapy and AD dementia: new findings from the Cache County study. Neurology 2012;79:1846–52
   PubMed Web of Science ®Google Scholar
• Resnick SM, Henderson VW. Hormone therapy and risk of Alzheimer disease: a critical time. JAMA 2002;288:2170–2
   PubMed Web of Science ®Google Scholar
• Hemminki E, Malin M, Topo P. Selection to postmenopausal therapy by women’s characteristics. J Clin Epidemiol 1993;46:211–19
   PubMed Web of Science ®Google Scholar
• de Villiers TJ, Pines A, Panay N, et al. Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. Climacteric 2013;16:316–37
   PubMed Web of Science ®Google Scholar
• North American Menopause Society. The 2012 hormone therapy position statement of The North American Menopause Society. Menopause 2012;19:257–71
   PubMed Web of Science ®Google Scholar
• Szekely CA, Green RC, Breitner JC, et al. No advantage of A beta 42-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studies. Neurology 2008;70:2291–8
   PubMed Web of Science ®Google Scholar
• Wong WB, Lin VW, Boudreau D, Devine EB. Statins in the prevention of dementia and Alzheimer’s disease: a meta-analysis of observational studies and an assessment of confounding. Pharmacoepidemiol Drug Saf 2013;22:345–58
   PubMed Web of Science ®Google Scholar
• Jaturapatporn D, Isaac MG, McCleery J, Tabet N. Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer’s disease. Cochrane Database Systematic Rev 2012;15:CD006378
   Google Scholar
• McGuinness B, O’Hare J, Craig D, Bullock R, Malouf R, Passmore P. Statins for the treatment of dementia. Cochrane Database Systematic Rev 2010;8:CD007514
   PubMed Web of Science ®Google Scholar
• McGuinness B, Craig D, Bullock R, Passmore P. Statins for the prevention of dementia. Cochrane Database Systematic Rev 2009;2:cd003160
   PubMedGoogle Scholar
• Thal LJ, Ferris SH, Kirby L, et al. A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment. Neuropsychopharmacology 2005;30:1204–15
   PubMed Web of Science ®Google Scholar
• ,ADAPT Research GroupLyketsos CG, Breitner JC, et al. Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial. Neurology 2007;68:1800–8
   PubMed Web of Science ®Google Scholar
• Alzheimer’s Disease Anti-inflammatory Prevention Trial Research Group. Results of a follow-up study to the randomized Alzheimer’s Disease Anti-inflammatory Prevention Trial (ADAPT). Alzheimers Dement 2013;9:714–23
   PubMed Web of Science ®Google Scholar
• Piazza-Gardner AK, Gaffud TJ, Barry AE. The impact of alcohol on Alzheimer’s disease: a systematic review. Aging Ment Health 2013;17:133–46
   PubMed Web of Science ®Google Scholar
• Anstey KJ, Mack HA, Cherbuin N. Alcohol consumption as a risk factor for dementia and cognitive decline: meta-analysis of prospective studies. Am J Geriatr Psychiatry 2009;17: 542–55
   PubMed Web of Science ®Google Scholar
• Piazza-Gardner AK, Barry AE. Examining physical activity levels and alcohol consumption: are people who drink more active? Am J Health Promot 2012;26:e95–e104
   PubMedGoogle Scholar
• Au Yeung SL, Jiang CQ, Cheng KK, et al. Evaluation of moderate alcohol use and cognitive function among men using a Mendelian randomization design in the Guangzhou biobank cohort study. Am J Epidemiol 2012;175:1021–8
   PubMed Web of Science ®Google Scholar
• Sabia S, Elbaz A, Britton A, et al. Alcohol consumption and cognitive decline in early old age. Neurology 2014;82:332–9
   PubMed Web of Science ®Google Scholar
• Weissman MM, Bland RC, Canino GJ, et al. Cross-national epidemiology of major depression and bipolar disorder. JAMA 1996;276:293–9
   PubMed Web of Science ®Google Scholar
• Maki PM, Freeman EW, Greendale GA, et al. Summary of the National Institute on Aging-sponsored conference on depressive symptoms and cognitive complaints in the menopausal transition. Menopause 2010;17:815–22
   PubMed Web of Science ®Google Scholar
• Büchtemann D, Luppa M, Bramesfeld A, Riedel-Heller S. Incidence of late-life depression: a systematic review. J Affect Disord 2012;142:172–9
   PubMed Web of Science ®Google Scholar
• Ownby RL, Crocco E, Acevedo A, John V, Loewenstein D. Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry 2006;63:530–8
   PubMed Web of Science ®Google Scholar
• Diniz BS, Butters MA, Albert SM, Dew MA, Reynolds CFr. Late-life depression and risk of vascular dementia and Alzheimer’s disease: systematic review and meta-analysis of community-based cohort studies. Br J Psychiatry 2013;202: 329–35
   PubMed Web of Science ®Google Scholar
• Grinberg LT, Rüb U, Ferretti RE, et al. The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer’s disease. A precocious onset? Neuropathol Appl Neurobiol 2009;35:406–16
   PubMed Web of Science ®Google Scholar
• Green KN, Billings LM, Roozendaal B, McGaugh JL, LaFerla FM. Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer’s disease. J Neurosci 2006;30:9047–56
   Google Scholar
• Byers AL, Yaffe K. Depression and risk of developing dementia. Nat Rev Neurol 2011;3:323–31
   Google Scholar
• Singh B, Parsaik AK, Mielke MM, et al. Association of mediterranean diet with mild cognitive impairment and Alzheimer’s disease: a systematic review and meta-analysis. J Alzheimers Dis 2014;39:271–82
   PubMed Web of Science ®Google Scholar
• Martínez-Lapiscina EH, Clavero P, Toledo E, et al. Mediterranean diet improves cognition: the PREDIMED-NAVARRA randomised trial. J Neurol Neurosurg Psychiatry 2013;84: 1318–25
   PubMed Web of Science ®Google Scholar
• Xie L, Kang H, Xu Q, et al. Sleep drives metabolite clearance from the adult brain. Science 2013;342:373–7
   PubMed Web of Science ®Google Scholar
• Huang Y, Potter R, Sigurdson W, et al. Effects of age and amyloid deposition on Aβ dynamics in the human central nervous system. Arch Neurol 2012;69:51–8
   PubMed Web of Science ®Google Scholar
• Spira AP, Gamaldo AA, An Y, et al. Self-reported sleep and β-amyloid deposition in community-dwelling older adults. JAMA Neurol 2013;70:1537–43
   PubMed Web of Science ®Google Scholar
• Lim AS, Kowgier M, Yu L, Buchman AS, Bennett DA. Sleep fragmentation and the risk of incident Alzheimer’s disease and cognitive decline in older persons. Sleep 2013;36:1027–32
   PubMed Web of Science ®Google Scholar
• Ju YE, Lucey BP, Holtzman DM. Sleep and Alzheimer disease pathology – a bidirectional relationship. Nat Rev Neurol 2014;10:115–19
   PubMed Web of Science ®Google Scholar